Remote and reversible inhibition of neurons and circuits by small molecule induced potassium channel stabilization
Eva Auffenberg(TUM Klinikum), Christoph K. Thoeringer(Max Planck Institute of Psychiatry), Rainer Stoffel(Max Planck Institute of Psychiatry), Andreas Genewsky(Max Planck Institute of Psychiatry), Carsten T. Wotjak(Boehringer Ingelheim (Germany)), Gerhard Rammes(Max Planck Institute of Psychiatry), Manfred Uhr(Max Planck Institute of Psychiatry), Corinna Mattusch(Technical University of Munich), Angela Jurik(Technical University of Munich), Christian Namendorf(Max Planck Institute of Psychiatry), Martin Biel(Ludwig-Maximilians-Universität München), Roland M. Schmid(Tumkur University), Sven Moosmang(Boehringer Ingelheim (Germany)), Stylianos Michalakis(LMU Klinikum)
Cited by 17
Related Papers
Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B.
|Journal of Clinical Investigation|1998|737
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
|The Lancet Oncology|2012|550
Role of Hippocampal Ca<sub>v</sub>1.2 Ca<sup>2+</sup>Channels in NMDA Receptor-Independent Synaptic Plasticity and Spatial Memory
|Journal of Neuroscience|2005|428